查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1591779

心臟移植市場：按手術類型、最終用戶分類 - 全球預測 2025-2030 年

Heart Transplant Market by Surgery Type (Biventricular Pacing, Total Artificial Heart, Ventricular Assist Devices), End User (Cardiac Institutes, Hospitals) - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 188 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

心臟移植市場2023年估值為119.3億美元，預計到2024年將達到131億美元，複合年成長率為9.88%，預計到2030年將達到230.9億美元。

心臟移植市場包括與用健康的捐贈心臟替換患者患病或衰竭的心臟相關的醫療技術和程序。心臟移植的需要源於對傳統治療沒有反應的晚期心臟衰竭病例，這對於延長患者的生存至關重要。應用主要針對末期心臟疾病患者，健康和醫療部門是主要的最終用戶。市場成長受到心血管疾病盛行率上升、外科技術進步、免疫抑制治療改善、捐贈者意識提升計畫增加等因素的影響。 3D 列印心臟等技術創新以及器官保存和運輸方面的進步正在提高移植成功率並增加移植的地理範圍，凸顯了巨大的市場機會。挑戰包括全球捐贈心臟短缺、移植手術成本高昂以及需要複雜的術後護理，這些可能導致治療可用性的差異。有關器官捐贈的監管障礙和道德擔憂使市場擴張更加複雜。為了解決這些障礙，技術創新的重點是人造心臟和異種移植（xenotransplants）的開發，這有望成為器官短缺的長期解決方案。重點研究微創手術技術、更好的免疫抑制劑，以及利用人工智慧進行患者選擇和最佳捐贈者匹配，將為產業發展鋪平道路。該市場競爭激烈、研究密集型，其特點是研究機構、醫院和醫療保健公司之間因對永續和創新解決方案的需求而合作。要在這個市場保持領先地位，需要對研究和技術進行投資，以最佳化患者的治療效果和捐贈器官的利用，以滿足公司當前的需求和未來在心臟移植方面的挑戰。

主要市場統計
基準年[2023] 119.3億美元
預測年份 [2024] 131億美元
預測年份 [2030] 230.9億美元
複合年成長率（%） 9.88%

市場動態：揭示快速發展的心臟移植市場的關鍵市場洞察

供需的動態交互作用正在改變心臟移植市場。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，並了解消費行為及其對製造成本的影響，並更清楚地了解對採購趨勢的影響。

  • 市場促進因素
    • 對改善和改善生活品質的需求不斷增加
    • 隨著世界老年人口的增加，心血管疾病的盛行率不斷上升
    • 政府對研發活動的支持迅速增加
  • 市場限制因素
    • 缺乏熟練的外科醫生和捐助者短缺
  • 市場機會
    • 新興國家和已開發國家強勁的醫療保健支出
    • 機械循環支援裝置等新應用
  • 市場挑戰
    • 治療費用上漲

波特五力：駕馭心臟移植市場的策略工具

波特的五力框架是理解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解心臟移植市場的外部影響

外部宏觀環境因素在塑造心臟移植市場的績效動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並幫助他們做出積極主動的決策。

市場佔有率分析 了解心臟移植市場的競爭格局

對心臟移植市場的詳細市場佔有率分析可以對供應商績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位矩陣心臟移植市場供應商的績效評估

FPNV定位矩陣是評估心臟移植市場供應商的重要工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析和建議繪製心臟移植市場的成功之路

對於旨在加強其在全球市場的影響力的公司來說，心臟移植市場的策略分析至關重要。透過考慮關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：對當前市場環境的詳細審查、主要企業的廣泛資料、對其在市場中的影響力和整體影響力的評估。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 對改善和改善生活品質的需求不斷增加
      • 全世界心血管疾病的盛行率正在上升，老年人口也在增加。
      • 政府對研發活動的支持迅速增加
    • 抑制因素
      • 缺乏熟練的外科醫生和捐助者短缺
    • 機會
      • 開發中國家醫療保健支出的穩健性
      • 機械循環支援裝置等新應用
    • 任務
      • 治療費用高
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章依手術類型分類的心臟移植市場

  • 雙心室起搏
  • 全人工心臟
  • 輔助人工心臟

第7章心臟移植市場：依最終用戶分類

  • 心臟病研究所
  • 醫院

第8章美洲心臟移植市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第9章亞太地區心臟移植市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第10章 歐洲、中東和非洲心臟移植市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第11章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議

公司名單

  • Abbott Laboratories
  • Abiomed
  • Berlin Heart
  • Bivacor, Inc.
  • Boston Scientific Corporation
  • Calon Cardio-Technology Ltd.
  • CareDx, Inc.
  • Edwards Lifesciences
  • Fresenius Medical Care AG & Co. KGaA
  • GE Healthcare
  • Getinge AB
  • Jarvik Heart, Inc.
  • Johnson & Johnson Services, Inc.
  • LivaNova, Inc.
  • Medtronic PLC
  • SynCardia Systems, LLC
  • Terumo Europe NV
  • Thoratec Corporation
  • WL Gore & Associates
Product Code: MRR-437E9896A565

The Heart Transplant Market was valued at USD 11.93 billion in 2023, expected to reach USD 13.10 billion in 2024, and is projected to grow at a CAGR of 9.88%, to USD 23.09 billion by 2030.

The heart transplant market encompasses medical technologies and procedures associated with replacing a patient's diseased or failing heart with a healthy donor heart. The necessity for heart transplants is driven by advanced heart failure cases unresponsive to conventional treatments, making it crucial for extending patients' lives. Applications predominantly involve end-stage heart disease patients, making the health and medical sectors the primary end users. Market growth is influenced by factors such as rising incidences of cardiovascular diseases, advancement in surgical techniques, improved immunosuppressive therapies, and increased donor awareness programs. Innovations like 3D-printed hearts and advancements in organ preservation and transport underscore significant market opportunities, enhancing transplant success rates and increasing geographic accessibility to transplants. Challenges include a global shortage of donor hearts, high costs of transplant procedures, and complex post-operative care requirements, which can lead to disparities in treatment availability. Regulatory hurdles and ethical concerns regarding organ donation further complicate market expansion. To address these hurdles, innovation focuses on the development of artificial hearts and xenotransplantation (cross-species organ transplants), which promise a long-term solution to organ scarcity. Emphasizing research in minimally invasive surgical techniques, better immunosuppressive drugs, and harnessing AI for patient selection and optimum donor matching will provide avenues for industry advancement. The market nature is competitive and research-intensive, characterized by collaborations between research institutions, hospitals, and healthcare companies, driven by the need for sustainable and innovative solutions. Staying ahead in this market requires investing in research and technology that optimize patient outcomes and donor organ utilization, positioning businesses to meet both current demands and future challenges in heart transplants.

KEY MARKET STATISTICS
Base Year [2023] USD 11.93 billion
Estimated Year [2024] USD 13.10 billion
Forecast Year [2030] USD 23.09 billion
CAGR (%) 9.88%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Heart Transplant Market

The Heart Transplant Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Growing demand for improved and extended quality of life
    • Rising prevalence of cardiovascular disease coupled with rising geriatric population globally
    • Surge in government support for R&D activities
  • Market Restraints
    • Dearth of skilled surgeons and shortage of donors
  • Market Opportunities
    • Robust healthcare expenditure in developing and developed countries
    • Emerging application of mechanical circulatory support assist devices and other such devices
  • Market Challenges
    • High cost of the treatment

Porter's Five Forces: A Strategic Tool for Navigating the Heart Transplant Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Heart Transplant Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Heart Transplant Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Heart Transplant Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Heart Transplant Market

A detailed market share analysis in the Heart Transplant Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Heart Transplant Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Heart Transplant Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Heart Transplant Market

A strategic analysis of the Heart Transplant Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Heart Transplant Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Abiomed, Berlin Heart, Bivacor, Inc., Boston Scientific Corporation, Calon Cardio-Technology Ltd., CareDx, Inc., Edwards Lifesciences, Fresenius Medical Care AG & Co. KGaA, GE Healthcare, Getinge AB, Jarvik Heart, Inc., Johnson & Johnson Services, Inc., LivaNova, Inc., Medtronic PLC, SynCardia Systems, LLC, Terumo Europe N.V., Thoratec Corporation, and W. L. Gore & Associates.

Market Segmentation & Coverage

This research report categorizes the Heart Transplant Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Surgery Type, market is studied across Biventricular Pacing, Total Artificial Heart, and Ventricular Assist Devices.
  • Based on End User, market is studied across Cardiac Institutes and Hospitals.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing demand for improved and extended quality of life
      • 5.1.1.2. Rising prevalence of cardiovascular disease coupled with rising geriatric population globally
      • 5.1.1.3. Surge in government support for R&D activities
    • 5.1.2. Restraints
      • 5.1.2.1. Dearth of skilled surgeons and shortage of donors
    • 5.1.3. Opportunities
      • 5.1.3.1. Robust healthcare expenditure in developing and developed countries
      • 5.1.3.2. Emerging application of mechanical circulatory support assist devices and other such devices
    • 5.1.4. Challenges
      • 5.1.4.1. High cost of the treatment
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Heart Transplant Market, by Surgery Type

  • 6.1. Introduction
  • 6.2. Biventricular Pacing
  • 6.3. Total Artificial Heart
  • 6.4. Ventricular Assist Devices

7. Heart Transplant Market, by End User

  • 7.1. Introduction
  • 7.2. Cardiac Institutes
  • 7.3. Hospitals

8. Americas Heart Transplant Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Heart Transplant Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Heart Transplant Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
  • 11.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abbott Laboratories
  • 2. Abiomed
  • 3. Berlin Heart
  • 4. Bivacor, Inc.
  • 5. Boston Scientific Corporation
  • 6. Calon Cardio-Technology Ltd.
  • 7. CareDx, Inc.
  • 8. Edwards Lifesciences
  • 9. Fresenius Medical Care AG & Co. KGaA
  • 10. GE Healthcare
  • 11. Getinge AB
  • 12. Jarvik Heart, Inc.
  • 13. Johnson & Johnson Services, Inc.
  • 14. LivaNova, Inc.
  • 15. Medtronic PLC
  • 16. SynCardia Systems, LLC
  • 17. Terumo Europe N.V.
  • 18. Thoratec Corporation
  • 19. W. L. Gore & Associates

LIST OF FIGURES

  • FIGURE 1. HEART TRANSPLANT MARKET RESEARCH PROCESS
  • FIGURE 2. HEART TRANSPLANT MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL HEART TRANSPLANT MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL HEART TRANSPLANT MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL HEART TRANSPLANT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL HEART TRANSPLANT MARKET SIZE, BY SURGERY TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL HEART TRANSPLANT MARKET SIZE, BY SURGERY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL HEART TRANSPLANT MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL HEART TRANSPLANT MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS HEART TRANSPLANT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 11. AMERICAS HEART TRANSPLANT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. UNITED STATES HEART TRANSPLANT MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 13. UNITED STATES HEART TRANSPLANT MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC HEART TRANSPLANT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. ASIA-PACIFIC HEART TRANSPLANT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA HEART TRANSPLANT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA HEART TRANSPLANT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. HEART TRANSPLANT MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 19. HEART TRANSPLANT MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. HEART TRANSPLANT MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL HEART TRANSPLANT MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL HEART TRANSPLANT MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL HEART TRANSPLANT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. HEART TRANSPLANT MARKET DYNAMICS
  • TABLE 7. GLOBAL HEART TRANSPLANT MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL HEART TRANSPLANT MARKET SIZE, BY BIVENTRICULAR PACING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL HEART TRANSPLANT MARKET SIZE, BY TOTAL ARTIFICIAL HEART, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL HEART TRANSPLANT MARKET SIZE, BY VENTRICULAR ASSIST DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL HEART TRANSPLANT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL HEART TRANSPLANT MARKET SIZE, BY CARDIAC INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL HEART TRANSPLANT MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. AMERICAS HEART TRANSPLANT MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 15. AMERICAS HEART TRANSPLANT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 16. AMERICAS HEART TRANSPLANT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 17. ARGENTINA HEART TRANSPLANT MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 18. ARGENTINA HEART TRANSPLANT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 19. BRAZIL HEART TRANSPLANT MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 20. BRAZIL HEART TRANSPLANT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 21. CANADA HEART TRANSPLANT MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 22. CANADA HEART TRANSPLANT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 23. MEXICO HEART TRANSPLANT MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 24. MEXICO HEART TRANSPLANT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 25. UNITED STATES HEART TRANSPLANT MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 26. UNITED STATES HEART TRANSPLANT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 27. UNITED STATES HEART TRANSPLANT MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 28. ASIA-PACIFIC HEART TRANSPLANT MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 29. ASIA-PACIFIC HEART TRANSPLANT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 30. ASIA-PACIFIC HEART TRANSPLANT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 31. AUSTRALIA HEART TRANSPLANT MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 32. AUSTRALIA HEART TRANSPLANT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 33. CHINA HEART TRANSPLANT MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 34. CHINA HEART TRANSPLANT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 35. INDIA HEART TRANSPLANT MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 36. INDIA HEART TRANSPLANT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 37. INDONESIA HEART TRANSPLANT MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 38. INDONESIA HEART TRANSPLANT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 39. JAPAN HEART TRANSPLANT MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 40. JAPAN HEART TRANSPLANT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 41. MALAYSIA HEART TRANSPLANT MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 42. MALAYSIA HEART TRANSPLANT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 43. PHILIPPINES HEART TRANSPLANT MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 44. PHILIPPINES HEART TRANSPLANT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 45. SINGAPORE HEART TRANSPLANT MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 46. SINGAPORE HEART TRANSPLANT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 47. SOUTH KOREA HEART TRANSPLANT MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 48. SOUTH KOREA HEART TRANSPLANT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 49. TAIWAN HEART TRANSPLANT MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 50. TAIWAN HEART TRANSPLANT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 51. THAILAND HEART TRANSPLANT MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 52. THAILAND HEART TRANSPLANT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 53. VIETNAM HEART TRANSPLANT MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 54. VIETNAM HEART TRANSPLANT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 55. EUROPE, MIDDLE EAST & AFRICA HEART TRANSPLANT MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 56. EUROPE, MIDDLE EAST & AFRICA HEART TRANSPLANT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 57. EUROPE, MIDDLE EAST & AFRICA HEART TRANSPLANT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 58. DENMARK HEART TRANSPLANT MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 59. DENMARK HEART TRANSPLANT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 60. EGYPT HEART TRANSPLANT MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 61. EGYPT HEART TRANSPLANT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 62. FINLAND HEART TRANSPLANT MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 63. FINLAND HEART TRANSPLANT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 64. FRANCE HEART TRANSPLANT MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 65. FRANCE HEART TRANSPLANT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 66. GERMANY HEART TRANSPLANT MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 67. GERMANY HEART TRANSPLANT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 68. ISRAEL HEART TRANSPLANT MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 69. ISRAEL HEART TRANSPLANT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 70. ITALY HEART TRANSPLANT MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 71. ITALY HEART TRANSPLANT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 72. NETHERLANDS HEART TRANSPLANT MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 73. NETHERLANDS HEART TRANSPLANT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 74. NIGERIA HEART TRANSPLANT MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 75. NIGERIA HEART TRANSPLANT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 76. NORWAY HEART TRANSPLANT MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 77. NORWAY HEART TRANSPLANT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 78. POLAND HEART TRANSPLANT MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 79. POLAND HEART TRANSPLANT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 80. QATAR HEART TRANSPLANT MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 81. QATAR HEART TRANSPLANT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 82. RUSSIA HEART TRANSPLANT MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 83. RUSSIA HEART TRANSPLANT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 84. SAUDI ARABIA HEART TRANSPLANT MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 85. SAUDI ARABIA HEART TRANSPLANT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 86. SOUTH AFRICA HEART TRANSPLANT MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 87. SOUTH AFRICA HEART TRANSPLANT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 88. SPAIN HEART TRANSPLANT MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 89. SPAIN HEART TRANSPLANT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 90. SWEDEN HEART TRANSPLANT MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 91. SWEDEN HEART TRANSPLANT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 92. SWITZERLAND HEART TRANSPLANT MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 93. SWITZERLAND HEART TRANSPLANT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 94. TURKEY HEART TRANSPLANT MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 95. TURKEY HEART TRANSPLANT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 96. UNITED ARAB EMIRATES HEART TRANSPLANT MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 97. UNITED ARAB EMIRATES HEART TRANSPLANT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 98. UNITED KINGDOM HEART TRANSPLANT MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 99. UNITED KINGDOM HEART TRANSPLANT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 100. HEART TRANSPLANT MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 101. HEART TRANSPLANT MARKET, FPNV POSITIONING MATRIX, 2023